Viatris VTRS
NASDAQ VTRS
$17.60 +0.14 (+0.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Viatris (VTRS) Short-term Investments (2020)

Updated

Viatris' Short-term Investments was $11.41 billion in Q3 2020, unchanged from the prior quarter.

Analysis

Viatris (VTRS) Short-term Investments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Viatris 20.05 Bn 15.07 Bn 1.46 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2020 11.41 Bn
Jun 28, 2020 11.41 Bn
API Access

Viatris Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=VTRS&period=max&api_key=YOUR_API_KEY